These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29076382)
1. Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis. Nuvolone M; Merlini G Expert Opin Ther Targets; 2017 Dec; 21(12):1095-1110. PubMed ID: 29076382 [TBL] [Abstract][Full Text] [Related]
2. An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis. Obici L; Merlini G Expert Opin Investig Drugs; 2014 Sep; 23(9):1239-51. PubMed ID: 25003808 [TBL] [Abstract][Full Text] [Related]
3. Systemic amyloidosis: novel therapies and role of biomarkers. Nuvolone M; Merlini G Nephrol Dial Transplant; 2017 May; 32(5):770-780. PubMed ID: 27540044 [TBL] [Abstract][Full Text] [Related]
4. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis. Comenzo RL Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis, diagnosis and treatment of systemic amyloidosis. Pepys MB Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801 [TBL] [Abstract][Full Text] [Related]
8. [Amyloidosis: a model of misfolded protein disorder]. Grateau G; Verine J; Delpech M; Ries M Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206 [TBL] [Abstract][Full Text] [Related]
14. Recent progress in the understanding and treatment of transthyretin amyloidosis. Sekijima Y J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898 [TBL] [Abstract][Full Text] [Related]
15. Drug development for cancer chemoprevention: focus on molecular targets. Johnson KA; Brown PH Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment in systemic amyloidosis]. Ikeda S Rinsho Byori; 2008 Feb; 56(2):121-9. PubMed ID: 18404826 [TBL] [Abstract][Full Text] [Related]
17. Drugs in clinical development for the treatment of amyotrophic lateral sclerosis. Martinez A; Palomo Ruiz MD; Perez DI; Gil C Expert Opin Investig Drugs; 2017 Apr; 26(4):403-414. PubMed ID: 28277881 [TBL] [Abstract][Full Text] [Related]
18. Emerging Advances in the Management of Cardiac Amyloidosis. Vranian MN; Sperry BW; Valent J; Hanna M Curr Cardiol Rep; 2015 Nov; 17(11):100. PubMed ID: 26374453 [TBL] [Abstract][Full Text] [Related]